Chiara Lucrezia Deantoni

Author

Istituti di Ricovero e Cura a Carattere Scientifico ORCID

Also Known As

Agostina De Stefani, C. Deantoni, C. L. Deantoni, C.L. Deantoni, C.L. deantoni, Chiara Lucrezia Deantoni, Chiara Deantoni, Chiara L. Deantoni, Chiara Lucrezia Deantoni, Deantoni, Chiara Lucrezia

138

Publications

594

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Vita-Salute San Raffaele University Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele San Raffaele University of Rome European Institute of Oncology

About

Chiara Lucrezia Deantoni is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	368
2	Health Sciences	2	2	112
3	Radiation Medicine	2	2	119
4	Surgical Oncology	1	1	137
5	Biomedical Imaging	1	1	24

Chiara Lucrezia Deantoni

Publications

528

Citations

H-Index

Page 1

	Year	Citations
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy Elise De Bleser, Barbara Alicja Jereczek‐Fossa, Thomas Zilli, European Urology Surgical OncologyUrologyRadiation TherapyMetastasis-directed TherapyMedicine	2019	137
Higher-than-expected Severe (Grade 3–4) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients C. Cozzarini, C. Fiorino, Chiara Lucrezia Deantoni, European Urology Urogenital RadiologyRadiation MedicineUrologyRadiation TherapyHigher-than-expected Severe	2014	107
Dose–volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation C. Sini, C. Fiorino, L. Perna, Radiotherapy and Oncology Radiation TherapyDose–volume EffectsMedicineRadiation EffectHematology	2015	100
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I–II Study N.G. Di Muzio, Andrei Fodor, B. Noris Chiorda, Clinical Oncology UrologyBiomedical ImagingBenign Prostatic HyperplasiaSimultaneous Integrated BoostProstatic Disease	2016	24
Real-world validation of Artificial Intelligence-based Computed Tomography auto-contouring for prostate cancer radiotherapy planning Gabriele Palazzo, P. Mangili, Chiara Lucrezia Deantoni, Physics and Imaging in Radiation Oncology	2023	23
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases Chiara Lucrezia Deantoni, Andrei Fodor, C. Cozzarini, British Journal of Radiology	2020	20
Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy Roberta Castriconi, Pier Giorgio Esposito, Alessia Tudda, Frontiers in Oncology	2021	20
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized? Andrei Fodor, Chiara Brombin, P. Mangili, The Breast	2020	16
Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse Guillermo Lorenzo, N. Di Muzio, Chiara Lucrezia Deantoni, iScience	2022	15
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers Luca Bergamaschi, Maria Giulia Vincini, Mattia Zaffaroni, Supportive Care in Cancer	2023	15

Page 1